Showing 4,241 - 4,260 results of 314,780 for search '"2"', query time: 0.50s Refine Results
  1. 4241
  2. 4242

    “Unmasking the Uncommon”: A case series of multi-drug resistant Elizabethkingia meningoseptica causing late-onset sepsis and meningitis in preterm neonates [version 2; peer review: 2 approved] by Anisha Maria Fernandes, Sinchana Bhat, Suchitra Shenoy M., Prajnha U.P.

    Published 2025-02-01
    “…IV Vancomycin was administered, which resulted in clinical improvement and negative blood culture results. Case 2 was an eleven-day-old preterm, low-birth-weight baby who presented with fever. …”
    Get full text
    Article
  3. 4243
  4. 4244

    Electrical Transport Properties of (Bi1.6Pb0.4Sr2Ca2Cu3O10)/Ag Tapes with Different Nanosized MgO by Nabil A. A. Yahya, R. Abd-Shukor

    Published 2013-01-01
    “…MgO nanopowders with average size 20 and 40 nm were introduced into (Bi1.6Pb0.4Sr2Ca2Cu3O10)(MgO)x (x=0–0.15 wt.%) in the pellet form. …”
    Get full text
    Article
  5. 4245

    Towards an ontology of mental health: Protocol for developing an ontology to structure and integrate evidence regarding anxiety, depression and psychosis [version 2; peer review: 1 approved, 2 approved with reservations] by Jennifer Potts, Micaela Santilli, Claire Friedrich, Jaycee Kennett, Janna Hastings, Susan Michie, Paulina M. Schenk

    Published 2024-11-01
    “…Methods We will develop and apply the GALENOS Mental Health Ontology through eight steps: (1) defining the ontology’s scope; (2) identifying, labelling and defining the ontology’s entities for the GALENOS living systematic reviews; (3) structuring the ontology’s upper level (4) refining entities via iterative stakeholder consultations regarding the ontology’s clarity and scope; (5) formally specifying the relationships between entities in the Mental Health Ontology; (6) making the ontology machine-readable and available online; (7) integrating the ontology into the data repository; and (8) exploring the ontology-structured repository’s usability. …”
    Get full text
    Article
  6. 4246
  7. 4247

    Antagonistic Effects of Sublethal Concentrations of Certain Mixtures of Metal Oxide Nanoparticles and the Bulk (Al2O3, CuO, and SiO2) on Gill Histology in Clarias gariepinus by Amaeze Henry Nnamdi, Tam-Miette Dawarri Briggs, Oluwaseun Olusola Togunde, Henry Ebele Obanya

    Published 2019-01-01
    “…This study evaluates the toxicity of joint effects of these different metal nanoparticles and their bulk in mixtures (Al2O3, CuO, and SiO2) on fish using histological biomarker. …”
    Get full text
    Article
  8. 4248

    Synthesis and Antimicrobial Activity of 3-Cyano-4-imino-9-methoxy-4H-pyrimido [2, 1-b] pyrimido [4, 5-b] quinoline and 2-Substituted Derivatives by S. P. Vartale, N. K. Halikar, Y. D. Pawar

    Published 2013-01-01
    “…The 2-amino-7-methoxypyrimido[4,5-b]quinoline (1) on treatment with bis(methylthio)methylene malononitrile (2) in ethyl alcohol and catalytic amount of TEA gives 3-cyano-4-imino-9-methoxy-2-methythio-4H-pyrimido[2,1-b]pyrimido[4,5-b]quinoline (3). …”
    Get full text
    Article
  9. 4249
  10. 4250
  11. 4251

    Education programmes on performance-based assessment for allied health and nursing clinical educators: A scoping review protocol [version 2; peer review: 1 approved, 2 approved with reservations] by Lucy Alpine, Emer Barrett, David Mockler, Anne O'Connor, Julie Broderick

    Published 2024-01-01
    “…Relevant English language publications will be sought from January 2000 to October 2022. Two reviewers will screen all titles and abstracts against the inclusion/exclusion criteria, and publications deemed relevant will be eligible for full text screening, confirming appropriateness for inclusion in the scoping review. …”
    Get full text
    Article
  12. 4252
  13. 4253
  14. 4254
  15. 4255
  16. 4256

    Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C18H17NO3 by Wang Lei, Meng Qing-Guo, Jiang Nan, Wei Lin, Wang Chun-Hua

    Published 2021-09-01
    “…C18H17NO3, monoclinic, P21/n (no. 14), a = 14.702(3) Å, b = 7.0421(11) Å, c = 15.303(3) Å, β = 113.32(2)°, V = 1454.9(5) Å3, Z = 4, Rgt(F) = 0.0522, wRref(F2) = 0.1274, T = 100.03(18) K.…”
    Get full text
    Article
  17. 4257
  18. 4258

    Crystal structure of 2-(2-hydroxy-5-nitrophenyl)-5-methyl-1,3-dioxane-5-carboxylic acid, C12H13N1O7 by Jia Guo-Kai, Yuan Xian-You

    Published 2022-08-01
    “…C12H13N1O7, monoclinic, P21/c (no. 14), a = 11.416(7) Å, b = 13.860(8) Å, c = 8.215(5) Å, β = 99.607(6)°, V = 1281.6(13) Å3, Z = 4, Rgt(F) = 0.0433, wRref(F2) = 0.1274, T = 293(2) K.…”
    Get full text
    Article
  19. 4259

    Crystal structure of 9-fluoro-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine, C18H15FN4O by Li Xing-Wei, Miao Yu-Hao, Ding Yue-Xia, Hou Gui-Ge

    Published 2025-02-01
    “…C18H15FN4O, monoclinic, P21/c (no. 14), a = 18.0993(7) Å, b = 6.8868(3) Å, c = 24.8450(12) Å, β = 90.515(4)°, V = 3,096.7(2) Å3, Z = 8, R gt(F) = 0.0417, wR ref(F 2) = 0.1040, T = 293 K.…”
    Get full text
    Article
  20. 4260